Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase recruitment domain-containing protein 10 (CARD10) is a member of the CARD-CC protein family, acting as a scaffold protein that mediates activation of NF-κB signaling, typically via interactions with BCL10 or EGFR. CARD10 contains a caspase recruitment domain, a specialized protein-protein interaction module, and is also part of the membrane-associated guanylate kinase (MAGUK) family. Through its function, it participates in cellular signal transduction processes, is relevant in immune and inflammatory responses, and has been implicated in the pathogenesis of cancer and inflammatory diseases.
Drugs targeting CARD10 (if any) would likely act through modulation of NF-κB signaling or inhibition of scaffolding interactions with BCL10 or EGFR
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase recruitment domain-containing protein 10 (CARD10).